ABOS
Acumen Pharmaceuticals Inc
2.70$
+3.1%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 0.06 | 0.05 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.30 | 0.28 | 0.32 | 0.00 | 0.87 | 0.00 | 0.00 | |
| -0.24 | -0.23 | -0.32 | 0.00 | -0.87 | 0.00 | 0.00 | |
| 0.30 | 0.28 | 0.32 | 0.80 | 0.87 | 1.56 | 1.73 | |
| 0.03 | 0.05 | 0.19 | 0.32 | 0.39 | 0.34 | 0.31 | |
| 0.03 | 0.05 | 0.19 | 1.11 | 1.26 | 1.90 | 2.04 | |
| -0.27 | -0.28 | -0.51 | -1.11 | -1.26 | -1.90 | -2.04 | |
| 0.00 | 0.00 | 2.12 | 0.06 | 0.01 | 0.07 | 0.07 | |
| -0.28 | -0.26 | -2.63 | -1.06 | -1.08 | -1.71 | -2.00 | |
| 0.00 | 0.00 | 2.12 | -0.06 | – | – | – | |
| -0.28 | -0.26 | -2.63 | -1.06 | -1.08 | -1.71 | -2.00 | |
| 0.00 | -0.28 | -2.63 | -1.05 | -1.06 | -1.63 | -1.93 |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.